Projekt

Bevacizumab, pemetrexed and cisplatin, or erlotinib and bevacizumab for advanced non-squamous NSCLC stratified by EGFR mutation status. A multicenter phase II trial including biopsy at progression (BIO-PRO trial)

Automatisch geschlossen · 2010 bis 2014

Früh Martin, Siano Marco